Literature DB >> 17556303

Peritoneal dialysis in patients with diabetes: are the benefits greater than the disadvantages?

Satoru Kuriyama1.   

Abstract

Diabetic nephropathy has been increasing in prevalence in recent years, and it is now the dominant cause of end-stage renal disease (ESRD) worldwide. Because diabetes is frequently associated with multiple complications, nephrologists must be alert to the selection of dialysis modality so as to reduce the accompanying risks. The present review addresses whether the benefits of peritoneal dialysis are greater than its disadvantages in diabetic patients. The answer is quite positive: for most diabetic patients, peritoneal dialysis offers multiple benefits.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17556303

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  10 in total

1.  Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: a randomized controlled trial.

Authors:  Yuji Takatori; Shigeru Akagi; Hitoshi Sugiyama; Junko Inoue; Shoichiro Kojo; Hiroshi Morinaga; Kazushi Nakao; Jun Wada; Hirofumi Makino
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-14       Impact factor: 8.237

2.  Better outcomes of peritoneal dialysis in diabetic patients in spite of risk of loss of autonomy for home dialysis.

Authors:  P Cotovio; A Rocha; M J Carvalho; L Teixeira; D Mendonça; A Cabrita; A Rodrigues
Journal:  Perit Dial Int       Date:  2014-01-02       Impact factor: 1.756

3.  Peritonitis is still an important factor for withdrawal from peritoneal dialysis therapy in the Tokai area of Japan.

Authors:  Masashi Mizuno; Yasuhiko Ito; Akio Tanaka; Yasuhiro Suzuki; Hideki Hiramatsu; Midoriko Watanabe; Yoshikazu Tsuruta; Teppei Matsuoka; Isao Ito; Hiroshi Tamai; Hirotake Kasuga; Hideaki Shimizu; Hisashi Kurata; Daijo Inaguma; Takeyuki Hiramatsu; Masanobu Horie; Tomohiko Naruse; Shoichi Maruyama; Enyu Imai; Yukio Yuzawa; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2011-06-21       Impact factor: 2.801

4.  Perspectives of patients, families, and health care professionals on decision-making about dialysis modality--the good, the bad, and the misunderstandings!

Authors:  Konstadina Griva; Zhi Hui Li; Alden Yuanhong Lai; Meng Chan Choong; Marjorie Wai Yin Foo
Journal:  Perit Dial Int       Date:  2012-11-01       Impact factor: 1.756

5.  Predictors of peritonitis and the impact of peritonitis on clinical outcomes of continuous ambulatory peritoneal dialysis patients in Taiwan--10 years' experience in a single center.

Authors:  Yao-Peng Hsieh; Chia-Chu Chang; Yao-Ko Wen; Ping-Fang Chiu; Yu Yang
Journal:  Perit Dial Int       Date:  2013-10-01       Impact factor: 1.756

6.  Peritoneal dialysis in diabetics: there is room for more.

Authors:  P Cotovio; A Rocha; A Rodrigues
Journal:  Int J Nephrol       Date:  2011-10-16

7.  Relationship between trajectories of serum albumin levels and technique failure according to diabetic status in peritoneal dialysis patients: A joint modeling approach.

Authors:  Mehri Khoshhali; Iraj Kazemi; S Mohsen Hosseini; Shiva Seirafian
Journal:  Kidney Res Clin Pract       Date:  2017-06-30

8.  Peritoneal dialysis related infections in a tertiary care hospital in Riyadh, Saudi Arabia.

Authors:  Somia M Alfayez; Shahd M Alsaqoub; Abeer Y Qattan; Mada A Alghamdi; Dalia S Elfeky; Fadel A Alrowaie; Doaa S Aljasser; Sadiqa B Syed
Journal:  Saudi Med J       Date:  2019-02       Impact factor: 1.484

9.  Pneumonia and mortality risk in continuous ambulatory peritoneal dialysis patients with diabetic nephropathy.

Authors:  Feng He; Xianfeng Wu; Xi Xia; Fenfen Peng; Fengxian Huang; Xueqing Yu
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

10.  Diabetic patients could do as well as non-diabetic patients without inflammation on peritoneal dialysis.

Authors:  Rong Xu; QingFeng Han; TongYing Zhu; Yeping Ren; JiangHua Chen; HuiPing Zhao; MengHua Chen; Jie Dong; Yue Wang; ChuanMing Hao; Rui Zhang; Xiaohui Zhang; Mei Wang; Na Tian; HaiYan Wang
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.